JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events (Q65543075)

From Wikidata
(Redirected from Q6109138)
Jump to navigation Jump to search
clinical trial
  • JUPITER trial
edit
Language Label Description Also known as
English
JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events
clinical trial
  • JUPITER trial

Statements

A Randomized, Double-Blind, Placebo Controlled, Multicenter, Phase 3 Study of Rosuvastatin (CRESTOR®) 20 mg in the Prevention of Cardiovascular Events Among Subjects With Low Levels of Low Density Lipoprotein(LDL) Cholesterol & Elevated Levels of C-Reactive Protein (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
February 2003
0 references
September 2008
0 references
17,802
0 references
50 year
0 references

Identifiers

 
edit
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit